Sintx Technologies Reports Substantial Going Concern Doubt Amidst Increased Q1 Cash Burn and Ongoing Dilution

summarizeSummary

Sintx Technologies reported a wider net loss and significantly increased cash burn in Q1 2026, leading management to express substantial doubt about its ability to continue as a going concern, despite some revenue growth and ongoing ATM financing.

check_boxKey Events

• Substantial Doubt About Going Concern

  Management has concluded that substantial doubt remains regarding the company's ability to continue as a going concern for at least 12 months due to ongoing operating losses and cash usage.

• Increased Net Loss and Cash Burn

  Net loss widened to $2.8 million in Q1 2026 from $2.3 million in Q1 2025. Net cash used in operating activities significantly increased to $2.5 million from $1.3 million year-over-year, reducing cash to $1.89 million.

• Ongoing ATM Dilution

  The company sold $0.7 million under its ATM program in Q1 2026 and an additional $0.5 million subsequent to quarter-end, with $5.7 million remaining capacity.

• Revenue Growth from Continuing Operations

  Total revenue increased 3% to $380K in Q1 2026. Excluding the divested TA&T subsidiary, total revenue increased 46%, driven by spine-related products and OEM manufacturing.

auto_awesomeAnalysis

Sintx Technologies reported a wider net loss of $2.8 million in Q1 2026, up from $2.3 million in Q1 2025, and a significant increase in cash used in operating activities to $2.5 million from $1.3 million year-over-year. This substantial cash burn reduced cash and cash equivalents from $4.14 million at year-end 2025 to $1.89 million by March 31, 2026. Consequently, management has explicitly stated substantial doubt about the company's ability to continue as a going concern for the next 12 months. While total revenue increased 3% to $380K (or 46% excluding a divested subsidiary), and the company is shifting resources towards commercialization following FDA clearance, these efforts are currently insufficient to offset the liquidity challenges. The company continues to rely on its At-The-Market (ATM) program, having sold $0.7 million in Q1 2026 and an additional $0.5 million post-quarter, which provides capital but also results in ongoing dilution.